BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28402147)

  • 21. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of inclusion complex of brinzolamide with hydroxypropyl-β-cyclodextrin.
    Zhang Y; Ren K; He Z; Li H; Chen T; Lei Y; Xia S; He G; Xie Y; Zheng Y; Song X
    Carbohydr Polym; 2013 Oct; 98(1):638-43. PubMed ID: 23987393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
    Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation.
    Qiu N; Cheng X; Wang G; Wang W; Wen J; Zhang Y; Song H; Ma L; Wei Y; Peng A; Chen L
    Carbohydr Polym; 2014 Jan; 101():623-30. PubMed ID: 24299819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B; Zhong S; Li N; Li X; Yi J; Jin M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation, characterization and in vivo evaluation of a formulation of dantrolene sodium with hydroxypropyl-β-cyclodextrin.
    Chen M; Wu Q; Jiang J; Jin X; Liu S; Wang M; Zhao C
    J Pharm Biomed Anal; 2017 Feb; 135():153-159. PubMed ID: 28027523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity.
    Tang P; Ma X; Wu D; Li S; Xu K; Tang B; Li H
    Carbohydr Polym; 2016 May; 142():16-23. PubMed ID: 26917368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation and characterization of dihydroartemisinin/ hydroxypropyl-beta-cyclodextrin inclusion complex].
    Chen FW; Guo T; Li HY; Guo Z; He ZG; Shi SL; Zhang JW
    Yao Xue Xue Bao; 2012 Apr; 47(4):529-34. PubMed ID: 22799039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation.
    Yao Y; Xie Y; Hong C; Li G; Shen H; Ji G
    Carbohydr Polym; 2014 Sep; 110():329-37. PubMed ID: 24906763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, characterization and antimicrobial activity of inclusion complex of biochanin A with (2-hydroxypropyl)-β-cyclodextrin.
    Nikolic IL; Savic IM; Popsavin MM; Rakic SJ; Mihajilov-Krstev TM; Ristic IS; Eric SP; Savić-Gajic IM
    J Pharm Pharmacol; 2018 Nov; 70(11):1485-1493. PubMed ID: 30168133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of hydroxypropyl-β-cyclodextrin on the solubility, dissolution, cytotoxicity, and binding of riluzole with human serum albumin.
    Wang L; Yan J; Li Y; Xu K; Li S; Tang P; Li H
    J Pharm Biomed Anal; 2016 Jan; 117():453-63. PubMed ID: 26454338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
    Gundogdu E; Koksal C; Karasulu E
    Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS; Vavia PR
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
    Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
    Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
    Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.